[Federal Register Volume 84, Number 123 (Wednesday, June 26, 2019)]
[Notices]
[Pages 30121-30122]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-13522]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[30Day-19-0009]


Agency Forms Undergoing Paperwork Reduction Act Review

    In accordance with the Paperwork Reduction Act of 1995, the Centers 
for Disease Control and Prevention (CDC) has submitted the information 
collection request titled National Disease Surveillance Program--I. 
Case Reports to the Office of Management and Budget (OMB) for review 
and approval. CDC previously published a ``Proposed Data Collection 
Submitted for Public Comment and Recommendations'' notice on April 8, 
2019 to obtain comments from the public and affected agencies. CDC did 
not receive comments related to the previous notice. This notice serves 
to allow an additional 30 days for public and affected agency comments.
    CDC will accept all comments for this proposed information 
collection project. The Office of Management and Budget is particularly 
interested in comments that:
    (a) Evaluate whether the proposed collection of information is 
necessary for the proper performance of the functions of the agency, 
including whether the information will have practical utility;
    (b) Evaluate the accuracy of the agencies estimate of the burden of 
the proposed collection of information, including the validity of the 
methodology and assumptions used;
    (c) Enhance the quality, utility, and clarity of the information to 
be collected;
    (d) Minimize the burden of the collection of information on those 
who are to respond, including, through the use of appropriate 
automated, electronic, mechanical, or other technological collection 
techniques or other forms of information technology, e.g., permitting 
electronic submission of responses; and
    (e) Assess information collection costs.
    To request additional information on the proposed project or to 
obtain a copy of the information collection plan and instruments, call 
(404) 639-7570 or send an email to [email protected]. Direct written comments 
and/or suggestions regarding the items contained in this notice to the 
Attention: CDC Desk Officer, Office of Management and Budget, 725 17th 
Street NW, Washington, DC 20503 or by fax to (202) 395-5806. Provide 
written comments within 30 days of notice publication.

Proposed Project

    National Disease Surveillance Program--I. Case Reports (0920-0009, 
Exp. 6/30/2019)--Extension--National Center for Emerging and Zoonotic 
Infectious Diseases (NCEZID), Centers for Disease Control and 
Prevention (CDC).

Background and Brief Description

    Surveillance of the incidence and distribution of disease has been 
an important function of the US Public Health Service (PHS) since an 
1878 Act of Congress authorized the PHS to collect morbidity reports. 
After the Malaria Control in War Areas Program had fulfilled its 
original 1942 objective of reducing malaria transmission, its

[[Page 30122]]

basic tenets were carried forward and broadened by the formation of the 
Communicable Disease Center (CDC) in 1946. CDC was conceived of as a 
well-equipped, broadly staffed agency used to translate facts about 
analysis of morbidity and mortality statistics on communicable diseases 
and through field investigations.
    It was soon recognized that control measures (such as the DDT 
spraying for malaria) did not alleviate the threat of disease 
reintroduction. In 1950, the Malaria Surveillance Program began, and in 
1952, the National Surveillance Program started. Both programs were 
based on the premise that diseases cannot be diagnosed, prevented, or 
controlled until existing knowledge is expanded and new ideas developed 
and implemented. The original scope of the National Surveillance 
Program included the study of malaria, murine typhus, smallpox, 
psittacosis, diphtheria, leprosy, and sylvatic plague. Over the years, 
the mandate of CDC has broadened in preventive health activities and 
the surveillance systems maintained have expanded. This program is 
authorized under the Public Health Service Act, Section 301 and 306 (42 
U.S.C. 241 and 242K).
    This ICR covers surveillance activities for these four, rare 
diseases:
1. Creutzfeldt-Jakob Disease (CJD)
2. Reye Syndrome
3. Kawasaki syndrome
4. Acute Flaccid Myelitis
    Annual burden is estimated to decrease by 23 hours to 167 total 
hours since the last approval. There is no cost to respondents other 
than the time to participate.

                                        Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                                     Number of    Average burden
          Type of respondents                   Form name            Number of     responses per   per response
                                                                    respondents     respondent      (in hours)
----------------------------------------------------------------------------------------------------------------
Epidemiologists.......................  CJD.....................              10               2           20/60
                                        Kawasaki Syndrome.......              25              10           15/60
                                        Reye Syndrome...........              50               1           20/60
                                        Acute Flaccid Myelitis..             100               4           12/60
----------------------------------------------------------------------------------------------------------------


Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Scientific 
Integrity, Office of Science, Centers for Disease Control and 
Prevention.
[FR Doc. 2019-13522 Filed 6-25-19; 8:45 am]
 BILLING CODE 4163-18-P